Related Experiment Video
Updated: Mar 19, 2026
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Therapies in the pipeline for small-cell lung cancer
Ourania Romanidou1, Martina Imbimbo2, Giannis Mountzios3
1Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK Department of Medical Oncology, Papageorgiou General Hospital, Thessaloniki 56403, Greece.
Introduction Or Background:
Small-cell lung cancer (SCLC) represents ~15% of all cases of lung cancer and is characterized by a rapid tumour doubling time, early onset disease dissemination and high sensitivity to chemotherapy.
Sources Of Data:
We searched MEDLINE and OVID databases for articles in English published from January 1980 to February 2015.
Areas Of Agreement:
Platinum-based chemotherapy, thoracic radiotherapy and prophylactic cranial irradiation are standard of care. Benefit from second-line chemotherapy is limited.
Areas Of Controversy:
The role of platinum/irinotecan chemotherapy in the Western population and the role of maintenance therapies remain to be established.
Growing Points:
Knowledge of the biology of SCLC has expanded exponentially and many potential therapeutic targets have been identified.
Areas Timely For Developing Research:
The use of circulating tumour cells can help investigating molecular alterations occurring within tumour cells, understanding drug resistance mechanisms and evaluating new treatments.
More Related Videos
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies
02:49Cancer Therapies
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy